BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Cytokinetics, Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-01-13 4:56 pm Sale | 2021-01-11 | 13G | Cytokinetics, Incorporated CYTK | BIOTECHNOLOGY VALUE FUND L P | 2,728,035 3.900% | -4,629,984 (-62.92%) | Filing |
| 2020-11-16 5:29 pm Purchase | 2020-11-12 | 13G | Cytokinetics, Incorporated CYTK | BIOTECHNOLOGY VALUE FUND L P | 7,358,019 10.400% | 3,419,739 (+86.83%) | Filing |